Siegfried Janz

21PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 17, 2025
Molecular and immunological determinants of long-term survival in multiple myeloma.

Khanmi Kasomva, Kritika Yadav, Siegfried Janz

|Mar 05, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.

Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng

|Jan 19, 2024
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.

Fumou Sun, Yan Cheng, Visanu Wanchai

|Nov 03, 2023
Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance.

Christopher Staffi Buradagunta, Shahram Arsang-Jang, Ben Massat

|Oct 06, 2023
Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study.

Meera Mohan, Anai Kothari, Nathaniel Verhagen

|May 06, 2023
Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.

Meera Mohan, Siegfried Janz, Ruta Brazauskas

Pageof 4

Frequent Collaborators

9 joint publications

Anita D'Souza

7 joint publications

Jing Dong

6 joint publications

Binod Dhakal

5 joint publications

Parameswaran Hari